The tumour microenvironment (TME) forms a major obstacle in effective cancer treatment and for clinical success of immunotherapy. Conventional co-cultures have shed light into multiple aspects of cancer immunobiology, but they are limited by the lack of physiological complexity. We developed a novel human, organotypic skin melanoma culture (OMC) that allows real-time study of host-malignant cell interactions within a multi-cellular tissue architecture. By co-culturing keratinocytes, fibroblasts and immune cells with melanoma cells, onto a de-cellularized dermis, we generated a reconstructed TME that closely recapitulates tumour growth as observed in human lesions and supports cell survival and function. We demonstrate that the OMC is suitable and outperforms conventional 2D co-cultures for the study of TME-imprinting mechanisms. Within the OMC we observed the tumour-driven conversion of cDC2s into CD14 + DCs, characterized by a an immunosuppressive phenotype. The OMC provides a valuable complement to current approaches to study the TME.
Introduction
Targeting immunomodulatory pathways within the tumour microenvironment (TME) entered centre stage in cancer treatment 1 . Despite promising clinical results of novel cancer immunotherapies, such as immune checkpoint blockade to treat melanoma skin cancer, clinical efficacy is limited and only a minority of patients displays long-lasting clinical responses [2] [3] [4] . It is widely accepted that in particular an immunosuppressive TME represents a major hurdle to cancer clearance by immune cells 5, 6 . How such an immunosuppressive TME is induced is nowadays intensely studied. Human melanoma models that resemble the complex tissue architectures could improve our understanding of the contribution of the TME during anti-cancer therapy. This will be pivotal for the design of novel strategies that tackle immunosuppressive networks in melanoma to overcome immunotherapy failure 7 .
Over the past decades, a vast array of experimental approaches has been devised to study the melanoma TME, each presenting unique strengths and flaws 8, 9 . Those models range from twodimensional (2D) cultures to whole tissue explants. Albeit informative for basic aspects of cancer biology, 2D culture systems are a poor copy of the in vivo cellular environment, as they do not accurately mimic the meshwork of human tissues 10 . Cells in tissues face complex and structurally heterogeneous three-dimensional (3D) architectures and are exposed to a multitude of cellular and extracellular parameters, which influence tumour growth and the ability of stromal and immune cells to orchestrate immune responses locally 7, 11 . Tissue explants obtained from a patient's tumour can be cultured ex vivo for microscopic evaluation, or implanted into immunodeficient mice. Tissue explants and patient-derived xenografts (PDXs) retain cell-cell interactions as well as some tissue architecture of the original tumour and are very useful to monitor natural growth of cancer and to investigate tumour heterogeneity 12 . Nevertheless, PDXs lack a functional immune component, limiting their applicability for the study of therapeutic responses to immunotherapy 6 . On the other hand, patient-derived tumour explants can only assess pre-existing tumour immune infiltration (as found at the time of tissue resection), and as such only provide a snapshot. In conclusion, the human melanoma microenvironment including its immune cell components is difficult to mimic using current experimental models.
The potential of a human culture system that accurately mimics the in vivo situation, while having the benefit of a laboratory-controlled environment, has inspired researchers to develop 3D models of skin in which skin cancers, such as melanoma, can be propagated (also referred to as skin equivalents or organotypic cultures). In these models, human epidermal cells and melanoma cell lines, with different invasive capacities, are seeded onto fibroblasts-enriched, animal-derived collagen matrices [13] [14] [15] . Others developed organotypic cultures based on acellular, de-epidermized human dermis or self-assembled living sheets made with human fibroblasts secreting their own ECM, to obtain a model that more closely resembles the multifaceted skin tissue [16] [17] [18] [19] . However, despite important contributions to the field, organotypic skin cultures of melanoma that encompass both stromal-and immunocompetence have never been described 11 .
Intra-tumoural antigen-presenting dendritic cells (DCs) play an important role in stimulating tumour specific cytotoxic T cells, thus driving immune responses against cancer 20, 21 . Consensus nomenclature for immune myeloid cells classifies human DCs as conventional DCs (cDCs) and plasmacytoid DC (pDC). cDCs can be further subdivided into cDC1 (CD141 + DCs) and cDC2 (CD1c + DCs) subsets 22 . Despite their crucial role in anti-cancer immunity, evidence suggests that DCs in tumours become largely defective and are no longer capable to alert the immune system to cancer.
Furthermore, they are often outnumbered by other myeloid cell subsets, such as tumour-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) that actively suppress the immune system [23] [24] [25] . Moreover, we and others have recently described the enrichment of a myeloid cell population in cancer patients that co-expresses markers of monocytes/TAMs (such as CD14, CD163) and cDC2s (CD1c) [26] [27] [28] . Given their phenotypic distinction from monocytes and macrophages, these cells are called 'CD14 + DCs' 27 . CD14 + DCs are increased in the circulation of advance stage cancer patients and infiltrate both primary and metastatic tumour sites [26] [27] [28] . How these CD14 + DCs are generated remains yet to be determined.
Building on previous knowledge 19 , in this study we developed an organotypic skin melanoma culture (hereafter referred to as OMC), which contains both stromal and immune components. We validated our OMC by exploring functional plasticity of naturally circulating cDC2s that infiltrate the reconstructed melanoma tissue. Interestingly, we observed that the presence of a tumour within the engineered TME led to an extremely rapid transformation of normal immunostimulatory cDC2s into CD14 + DCs, with a phenotype matching their in vivo counterpart and an impaired ability to stimulate T cell proliferation. Our results highlight how the newly-generated OMC is instrumental to study tumour-induced events within the TME, that could otherwise not be addressed by static assessments of tissue biopsies.
Results

Human organotypic skin melanoma culture mimics natural primary human melanoma lesions
A de-cellularized dermis was used as a scaffold to generate organotypic skin melanoma cultures (OMCs, Fig. 1a ). Histochemical evaluation of dermal markers demonstrated that physical decellularization (outlined in the method section) of the human dermal scaffold did not disrupt its complex extracellular matrix architecture (elastin and collagen fibers), and preserved an intact basement membrane (BM) (Suppl Fig 1a,b) . Quantitative assessments of the de-cellularized dermis confirmed the lack of cellular (nuclei) and vascular (CD31) components ( Suppl Fig 1c-f ).
To generate a fully developed OMC, primary human fibroblasts (Fbs), keratinocytes (KCs) and melanoma cells are incorporated onto a de-epidermized dermis, and kept under specific culture conditions until a fully differentiated epidermal layer with interspersed tumour nests is formed (Fig   1a) . To mimic melanoma growth in the OMC, we co-seeded KCs with melanoma cells on the basal membrane layer, at different KC-to-tumour cell ratios. Immunohistochemistry analysis of model tissue sections and comparison to primary human tumour biopsies showed that the KC-to-tumour cell ratio is critical. At low KC:tumour cell ratios, extensive proliferation of melanoma cells negatively affects the morphology of the epidermal layer. Co-seeding large amounts of fast-diving tumour cells with epidermal cells, caused the tumour cells to outnumber KCs, thereby affecting KC differentiation and preventing the formation of the five characteristic epidermal strata characteristic for fully differentiated skin (Suppl. Fig 2) . The optimal cell seeding concentration, defined as the amount of KCs and melanoma cells that preserves epidermal differentiation and morphology, while allowing proliferation of tumour cells to form characteristic compact nests of cells that infiltrate the underneath dermis, was found to be 25 KCs:1 melanoma cell (Fig 1b, Suppl. Fig 2) .
As shown by multiplex fluorescence immunohistochemistry, melanoma cells and cancerassociated Fbs interact within the OMC (Fig. 1c) . Taken together, these observations show that the OMC clearly mimics the invasive growth of tumour cells into the dermis, closely resembling malignancy-associated lesions in human skin.
Human organotypic skin melanoma microenvironment facilitates tumour-immune cell interactions
A major objective to exploit OMCs is to study human host-tumour interactions, which is notoriously difficult in most xenograft models. In this study, we incorporated a major subset of DCs directly 6 isolated from the peripheral blood (cDC2s, phenotypically defined as CD1c + CD14 -) 26, 27 , into the dermal compartment of a fully differentiated OMC (day 19, Fig. 2a ).
After immunohistochemical staining, the distribution of cDC2s was assessed by reconstructing 20x images into overviews of entire tissue sections ( Fig. 2b-d , Suppl. Fig. 3 ). As a simple metric to quantify the cell density and location within the tissue area (or region of interest, 'ROI'; Suppl. Fig. 3b) , we computed the amount of immune cells and other cells (including stromal and epidermal cells), based on cell segmentation and positivity score using inForm (Fig. 2b, top panel). Enumeration of viable, single cDC2s was obtained with qualitative assessment of signal intensities, analogous to flow cytometry data, for cytometric image analysis as showed in Fig. 2b (bottom panel), followed by microscopic evaluation of gated live, defined as Cl. were homogeneously distributed throughout the reconstructed melanoma tissue (± 20 cDC2s counted per mm 2 ) indicating that immune cells easily migrate into the organotypic culture (Fig. 2d ).
Altogether, these findings demonstrate that the OMC is a potentially valuable tool to study immune cell behaviour within the TME.
Dendritic cells interact with melanoma cells and sample tumour-derived particles in a human organotypic skin melanoma microenvironment
Immunohistochemistry end point analysis of fixed OMCs revealed that cDC2s in the dermal compartment were in close proximity with both melanoma cells and cancer-associated Fbs (Fig 3a) .
To confirm that cDC2s actively interact with cells in their surrounding niche and engage in cell-tocell interactions with tumour cells, we exploited live two-photon microscopy with a time-lapse setting (Fig 3b-f) . Combination of fluorescent signal (live-cell visualization) with second harmonic generation (SHG, elicited by collagen fibre bundles) delivers important information on the 3D anatomy of OMCs. Like in natural skin, collagen fibers were organized in heterogeneous networks, including randomly arranged loose collagen fibers and aligned in more compacted collagen bundles (Fig. 3b , Suppl. Fig. 1a ). cDC2s were highly migratory, as evidenced by a typical "hand mirror shape" (Fig. 3c) , characteristic of amoeboid motility. cDC2s displayed a leading edge, consisting of multiple dendrites that intercalated between tissue structures, followed by the cell body containing the nucleus, and a posterior tail (uropod). Furthermore, we observed that GFP-expressing melanoma BLM cells (BLM-GFP) were confined by collagen fiber bundles, but showed intense membrane dynamics, evidenced by protrusive and retractile activity (Fig. 3d) . Interestingly, cDC2s in our OMC actively interacted with live tumour cells and even sampled tumour-derived cellular microparticles (or blebs), released by the BLM-GFP cells into the ECM (Fig 3e,f Figure 4b illustrate how, in the presence of melanoma, frequencies (mean ± SD) of cDC2s and CD14 + DCs change, towards rapid accumulation of the latter and a concomitant prominent reduction of cDC2s in the TME, compared to OSCs. This phenomenon was consistently observed throughout all experiments and independent of the melanoma cell line used (Fig 4c) . To further characterize these cells, we assessed whether differences in the expression of the monocytic marker, CD14, reflected additional changes characteristic for CD14 + DCs. Tumour-conditioned cDC2s displayed lower CD1c, CD86 and HLADR (GeoMFI CD14 + DCs/cDC2s ratio < 1.0) and had higher PDL1 expression (GeoMFI CD14 + DCs/cDC2s ratio > 1.0) (Fig. 4d) . Interestingly, besides CD14 upregulation, we found that CD14 + DCs expressed higher levels of markers typically associated to TAMs: CD163, CD206 and MerTK (GeoMFI CD14 + DCs/cDC2s ratio > 1.0) (Fig. 4e) . In order to investigate the importance of dimensionality in the tissue microenvironment, we performed intra-donor comparisons (n=4) of cDC2s, isolated from OMCs, to those co-cultured with the same tumour cells in conventional 2D co-cultures. Percentages of CD14 + DCs were significantly lower in 2D co-cultures (P=0.0109) compared to those isolated from OMCs ( Supplementary Fig 5a,b) , providing additional evidence for the importance of 3D organotypic cultures that clearly mimic a skin tissue microenvironment. Moreover, CD14 + DCs generated in 2D always failed to up-regulate CD163 and MerTK, and had a much lower expression of PDL1 compared to cells cultured in the OMC (Fig. 4f and Suppl. Fig 5c) . Altogether, these data demonstrate that: 1)
within the OMC the presence of a tumour rapidly drives cDC2s towards a different myeloid cell subset phenotypically resembling CD14 + DCs, 2) the observed phenomenon is tumour-dependent since OSCs lacking tumour cells contains significantly less cells expressing CD14, and 3) 3D multicellular skin cultures are essential, as a conventional 2D co-cultures do not recapitulate such phenotype.
Melanoma-induced CD14 + DCs display immunosuppressive function
To functionally characterize tumour-induced CD14 + DCs, we next performed qRT-PCR on cDC2s and CD14 + DCs FAC-sorted 18 hours post-injection. We confirmed at the transcriptomic level that CD14 + DCs from OMCs express CD14, CD163 and CD206 genes (data not shown), consistent with protein surface expression levels as measured by flow cytometry (Fig. 4d) . Interestingly, we observed that these CD14 + DCs generated within the OMC also expressed higher levels of markers previously linked to human myeloid cells endowed with suppressive activity: XBP1, THBS1, IL6, PTGS2 and HIF1A (Fig. 5a , Suppl. Fig 6a) 31,32 . At the protein expression level, we confirmed that only CD14 + DCs promptly produced IL-6 (0.64% vs 11%), upon TLR4 stimulation (Fig. 5b) . Intriguingly, we observed that these cells could also be distinguished based on their S100A9 expression ( Fig. 5c ), underlining another similarity to already described regulatory myeloid cell features 33 . Of note, the immunosuppressive molecule IDO1, often found in association with tolerogenic DCs 34 was predominantly expressed in cDC2s that still retained a clear DC phenotype upon interaction with tumour cells (Fig. 5a ). This suggests that within OMCs, injected cDC2s follow two different fates: 1) they become tolerogenic cDC2s; 2) they convert to CD14 + DCs. To further investigate if these cDC2s also functionally reverted to immunosuppressive myeloid cells, we performed mixed lymphocyte reactions to test their immunostimulatory potential. cDC2s that acquired CD14 during culture, were far less capable of stimulating allogenic CD3 + T cells when compared to cDC2s that lacked CD14 (Fig   5d) . Similarly, they were significantly less able to induce autologous T cell activation (Fig. 5e ). Of note, we observed that CD14 + DCs, isolated from OSCs, were already less stimulatory than cDC2s, but the presence of the tumour further decreased their ability to stimulate T cell proliferation and activation (Suppl. Fig. 6b,c) . Collectively, our data show that cDC2s that acquire CD14 within OMCs, represent a functional distinct myeloid population induced by the TME. 
CD14
Discussion
Recently, tumour organoids have received much attention 35, 36 . Organoids have the advantage of retaining both histological and mutational features of the original tumour, and can be propagated for extended periods of time, thus facilitating extensive experimenting. Yet, they fail to represent the multicellular composition of the TME 37 . In particular, the inclusion of stroma and tumourinfiltrating lymphocytes has been only recently described 37 . So far organoid cultures have mainly been generated from epithelial cancer types 35, 36, 38 , leaving the more complex skin tissue, where primary melanoma resides, still uncovered. In the context of human melanoma, local tumour growth was mimicked in in vitro skin equivalents, which however lacked an immune compartment 16 .
With the aim of filling this gap, we generated a novel human multicellular skin microenvironment, amenable to controlled experimental manipulation, suitable to explore cancer-driven immune cell modulation within a complex tissue architecture. Similar to organoids, the OMC we developed,
reproduces the spatial distribution of cells that naturally constitute the skin. In this respect, we observed that an optimal KC:tumour cell ratio is essential to ensure the formation of the epidermal layer, while allowing proliferation of tumour cells into nests that infiltrate the underneath dermis.
Organoids and tumor spheroids are developed using synthetic and animal-derived scaffolds.
However, these matrices, while ensuring the required tissue stiffness, may otherwise act as a source of foreign antigens 39 . Thus, de-cellularized human tissue like the one here employed, or synthetic matrices 40 potentially represents better alternatives for establishing an immunocompetent TME.
Interestingly, besides the illustrated use of primary naturally circulating DCs, we assessed the feasibility of culturing T lymphocytes within the OMC, and found that the percentage of live CD3 + CD4 + and CD3 + CD8 + cells was not affected by the culture conditions (Suppl. Fig. 8 ). Remarkably, the rapid changes (2 days) we observed on cDC2s cultured in OMCs, did not require the addition of exougenous growth factors or cytokines, which could per se potentially alter cell phenotype and function. Nevertheless, whether the use of supplemented culture media is required for longer culture periods or different immune cell subsets, remains to be explored.
As previously reported for patient-derived organoids and tumor spheroids, we also explored the use of the de-cellularized dermis as a scaffold for infusing material directly isolated from melanoma biopsies (Suppl. Fig. 9 ). The analysis of the lymphoid and myeloid populations, by means of multiplex IHC, assessed vitality and cellular distribution. Further experiments are desirable to confirm suitability of the human de-cellularized dermal scaffold to maintain tumour and immune representativeness of the original lesion.
The intra-tumoural infiltration and activation of myeloid cells, such as DCs, has clinical relevance across different tumour types 21 . Thus, understanding the mechanisms that regulate the fate of individual DC subsets within the TME will be pivotal to define strategies that revert DC immunosuppression while simultaneously enhancing their activation 41, 42 . Importantly, the behaviour of antigen-presenting cells in a tumor organoid-like context has never been addressed. We validated our model by following the response of circulating cDC2s within the reconstructed TME. cDC2s are phenotypically defined as CD1c + CD14 -and characterized by the ability to stimulate cytotoxic T cell responses, exemplified by their use in DC vaccination protocols 30 .
By combining imaging, flow cytometry and gene expression profiling we documented the interaction of cDC2s with stromal and melanoma cells within the OMC, and attested the local conversion of cDC2s into a distinct myeloid cell population. 31, 32 and, like monocytes and macrophages, have poor T cell stimulatory ability. The evolution of conventional DCs into regulatory macrophage-like cells has been proposed in murine models 44, 45 , but to our knowledge this is the first study that reports the ability of human, naturally-occurring, mature cDC2s to be reprogrammed into CD14 + DCs. Indeed, human in vitro studies investigating this phenomenon were performed using monocyte-derived DCs (moDCs), which represent a poor surrogate of in vivo DCs 46, 47 . It will now be critical to unravel the molecular drivers of the immunostimulatory cDC2s transition into regulatory CD14 + DCs, within tumour tissues. Of note, albeit the three melanoma cell lines, employed for the generation of the organotypic skin model, present differences in gene expression and secretome profiles (data not shown), we so far did not observe dissimilarities in their ability to promote cDC2 conversion.
Our results also support the hypothesis that the multicellular dimensionality of the TME plays a critical role in shaping cell phenotypes 7, 11 . We here showed that the phenotype of tumourinduced CD14 + DCs was not obtained in (parallel intra-donor) 2D co-culture experiments. In particular, although some expression of CD14 was observed, these cells failed to express the TAM markers, CD163 and MerTK.
The in vitro differentiation of myeloid cells to acquire TAM traits usually requires ³3 days 48, 49 .
In this respect, we believe that the rapid cDC2s conversion (2 days) could be explained by the fact that tumour and immune cells are not added in culture simultaneously, as usually performed in classical 2D co-culture experiments, but instead immune cells are exposed to an already tumourconditioned skin microenvironment. This certainly leads to a stronger tumour-mediated effect and more closely resembles the natural cDC2s entry into tumour tissues in vivo. We are aware that, like most organotypic culture systems, our OMC is limited by the absence of blood vessels and lymphatics, and thus events such as angiogenesis and leukocyte extravasation cannot be mimicked. In order to overcome this caveat, attempts have been made to engineer collagen matrices containing a microvasculature network of endothelial cells, or to integrate microfluidics with tissue engineering to mimic the function of native microvessels 51, 52 . Those approaches are still in their early infancy and further development is needed 53, 54 . However, we believe that our model could be employed to assess T cell infiltration, for the investigation of mechanisms governing inflamed versus not inflamed tumour tissues.
In the present study we describe the generation, characterization and one potential application of a novel OMC. In contrast to patient-derived tumour spheroids, this system does not aim to assess pre-existing immune infiltration 55 , but should be viewed as a fully titratable in vivolike environment for the advanced investigation of tumour-immunological mechanisms. Overall, we believe that the proposed OMC will contribute to the identification of candidate genes and molecules involved in immune escape processes. Ultimately, this might lead to the design of novel therapeutic targeted approaches addressing the melanoma microenvironment.
Materials & Methods
Cell culture, transduction and stable cell line development
Human melanoma cells (BLM, BLM-GFP, Mel624 and A375) were tested to be mycoplasma-free, authenticated by ATCC and maintained in Dulbecco's modified Eagle's medium (DMEM, Gibco), supplemented with 5% fetal calf serum and 5% CO2 humidified air at 37°C. The Lenti6/Block-iTshScramble (GFP) vector was a kind gift of Prof. Peter Friedl (RIMLS, The Netherlands). The sequence of this construct does not match any known mammalian genes. BLM cells were infected with lentiviral vector and (10µg/ml) polybrene and incubated at 37°C, 5% CO2, overnight. Then medium was refreshed and cells were analyzed after 72h of treatment. A stable cell line was selected with 5µg/ml blasticidin.
Isolation of human blood immune cells
Peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats obtained from healthy Table 1 ). Purity levels higher than 98% were achieved, determined by flow cytometry (Suppl. Fig. 4a ). For live imaging experiments, cDC2s were pre-labelled with the membrane dye PKH26 (Sigma-Aldrich) according to manufacturers' protocols and resuspended in X-VIVO-15 medium (Lonza) supplemented with 2% human serum (HS, Sanquin). Autologous or allogenic CD3 + T cells used in T cell co-culture experiments were isolated using the Pan T cell isolation kit (Miltenyi Biotec) following manufacturer's instruction.
Isolation of cellular and extracellular matrix human skin components
Generation of de-epidermized, de-cellularized dermis and isolation of human primary keratinocytes from human abdominal skin, derived from donors who underwent surgery for abdominal wall correction, was performed as previously described 56 . Briefly, human skin was incubated for five to ten minutes in phosphate-buffered saline (PBS) at 56°C to allow separation of the epidermis from the dermis. A de-epidermized human dermis was obtained by incubating the dermis for one month in PBS containing gentamicin (0.5 mg/ml; Life Technologies, Inc.) and antibiotic/antimycotic (Life 
Generation of the human organotypic skin melanoma culture
To generate the human organotypic skin melanoma culture (OMC), 8mm punch biopsy of deepidermized, de-cellularized dermis was placed carefully basal membrane side down on a transwell insert in a 24-well plate (24-wells ThinCert, Greiner Bio-One) and 0.25x10 6 fibroblasts were seeded onto the reticular dermal side (opposite to papillary side and basal membrane) of a de-epidermized dermis, via centrifugal force (day 1), in Fibroblast medium (3:1 DMEM: Ham's F12 Nutrient Mixture, Gibco) supplemented with 10% FCS. The plate was centrifuged for one hour at 500rpm. After centrifugation, the de-epidermized dermis was maintained in Fibroblast medium for two days at 37°C, to allow cellular proliferation and distribution through the structural collagen bundles and elastin fibers. After two days of culture, the repopulated de-epidermized dermis was turned basal membrane side up in the transwell insert and keratinocytes were seeded together with melanoma cells (BLM, Mel624 or A375) onto the papillary side of the dermal scaffold (day 3). The OMC was cultured submerged for three days in PONEC medium containing 5% serum (PONEC 5% medium), to allow proliferation of keratinocytes and tumour cells (day 6). PONEC 5% medium consists of two Calbiochem, San Diego, CA), L-serine (1mg/ml; Sigma), L-carnitine (2 µg/ml, sigma), bovine serum albumin lipid mix (palmitic acid 25 µmol/l; arachidonic acid 7 µmol/l; linoleic acid 15µmol/l; vitamin E 0.4µg/ml; all from Sigma), insulin (0.1 µmol/l; Sigma, St. Louis, MO), hydrocortisone (1 µmol/l; Merck, Darmstadt, Germany), triiodothyronine (1.36 ng/ml, Sigma), cholera toxin (10 -10 mol/L, Sigma), ascorbic acid (50 µg/ml; Sigma), keratinocyte growth factor (5 ng/ml, Sigma), epidermal growth factor (2 ng/ml, Sigma). At this point, the OMC was conditioned for two days with X-VIVO-15 medium (Lonza) supplemented with 5% human serum (Sanquin), to sustain survival of immune cells in the reconstructed microenvironment (day 19). Ex-vivo culture of immune cells, which can be freshly isolated from peripheral blood circulation or separated from the tissue they infiltrate, can be a critical procedure due to the fragile nature of those cell types when dissected from their original microenvironment. At day 19, 0.1 to 0.5 x10 6 cDC2s were microinjected into the dermis using a microneedle array system (kindly provided by Nanopass Technology Ltd, Israel). The microneedle array holder was connected to a manual syringe pump (1ml, BD). Microinjection was performed using air pressure. Care was taken not to allow the microneedles to rupture the regenerated skin.
Immunocompetent OMCs were cultured for additional two days in X-VIVO-15 medium plus 5% human serum. For experiments that assessed DC phenotype and function, melanoma cells were incorporated 1) together with Fbs onto the dermal scaffold (day 1), and 2) co-seeded with keratinocytes onto the basal membrane (day 3). The double seeding procedure of melanoma cells was performed to guarantee efficient melanoma conditioning of the reconstructed microenvironment, in a way that would more closely recapitulate in vivo tumour-associated tissues.
Patient material
Tumour specimens were collected from stage IV metastatic melanoma patients. The following cases were analyzed: Pt 1, metastasis at the right upper leg; Pt 2, metastasis at the right adrenal gland, Pt 3 liver metastasis. The study was approved by our Institutional Review Board and written informed consent was obtained from all patients.
Tumour dissociation
Melanoma cell suspensions were obtained from tumour sample of patients who underwent surgery by enzymatic and mechanic digestion using the gentleMACS Dissociator (Miltenyi, BergischGladbach, Germany). Briefly, tumour specimens were minced under sterile conditions into small pieces and digested over 1 h at 37 1C following the gentle MACS Dissociator protocol (Miltenyi). The resulting cell suspension was filtered through a 70-μm mesh (BD Biosciences, San Jose, CA, USA), the red blood cells were lysed, and the cell suspension was washed with RPMI. Cells were stored in liquid nitrogen until use. The same approach was used to process OMCs for the isolation and analysis of immune cells.
Immunohistochemistry and manual digital cell density analysis
Slides of 4 or 6-µm thickness were cut from formalin-fixed, paraffin-embedded (FFPE) primary melanoma tissue blocks and OMCs. Hematoxylin-Eosin (HE) and Elastica van Gieson histological stainings were performed according to standard protocols. For chromogenic immunohistochemistry, antigen retrieval was performed by rehydrating and boiling the slides in either Tris-EDTA buffer (pH9; 643901; Klinipath) for 10 min or in pronase (0,1% protease XIV, P5147-5G; Sigma) for 6 min at 37°C. Protein blocking was achieved using Normal Antibody Diluent 
Fluorescent multiplex immunohistochemistry
Formalin-fixed, paraffin-embedded (FFPE) OMCs were sectioned following a perpendicular orientation with respect to the direction of the epidermal layer (Suppl. Fig. 3a) . Tissue sections (6-µm thickness) cut at a distance of approximately 200µm were stained for fluorescent multiplex IHC.
Immunofluorescent visualization was performed, as previously described 57 
Tissue imaging and quantitative digital analysis
Whole tissue slides were imaged using Vectra Intelligent Slide Analysis System (Version 3.03, PerkinElmer Inc.). This imaging technology combines imaging and spectroscopy to collect entire spectra at every location of the image plane. Images of single stained tissues for each reagent were used to build spectral libraries of the single dyes by using the Nuance Multispectral Imaging System (Version 3.0.2, PerkinElmer Inc.). These spectral libraries were used to unmix the original multispectral images obtained with the Vectra imaging system (Suppl . Fig 3c) , to obtain an accurate and specific quantification of the cleaved Caspase 3 negative, CD45 positive (Cl. (tissue segmentation, cell segmentation and positivity score) as described previously 57, 58 . All settings applied to the training images were saved within an algorithm allowing batch analysis of multiple original multispectral images of the same tissue. Vectra Review (Version 2.0.8, PerkinElmer Inc.) was used to select the areas for analysis; this consisted of the entire reconstructed tissue. Both background area and tissue area (Region Of Interest or "ROI"; Suppl. Fig 3b) were defined by fullyautomated trainable tissue segmentation, based on morphological features and expression of DAPI (for efficient cell segmentation) and Tumor markers (for discrimination of areas containing tumour cells). A region of disinterest (ROD) was manually drawn in a qualitative manner over the stratum corneum, dermal border and injection site in order to reduce the auto-fluorescent signal caused by the structural characteristics of those regions. To appreciate the cell distribution patterns at low resolution, we clustered the cell positions using hierarchical mean linkage clustering, with a distance threshold of 150 mm (i.e., clusters whose centres were more than 150 mm apart were not joined).
Single-cell-based information was saved to a file format compatible with flow and image cytometry data analysis software FlowJo (Version 10, Treestar).
Time-lapse image acquisition and processing
All time-lapse experiments were performed using a multiparameter multiphoton microscope 
Flow Cytometry and Flow Cytometry Cell Sorting (FACS)
A complete list of antibodies used in the study is reported in Supplementary Table 1 . Dead cells were identified using Fixable Viability Dyes eFluor® 506 or 450 (Affymetrix, eBiosciences) and excluded from the analysis. For surface staining: cells were incubated in 2% human serum for the blocking of non-specific antibody binding to receptors (10 min, 4°C) and subsequently stained with directly labelled primary antibodies (30 min, 4°C) (Supplementary Table 1 ). For IL-6 intracellular staining: cells were stimulated with LPS (1μg/mL) for 6hrs and GolgiPlug (BD Biosciences) was added in the last 5hrs of the assay. After staining of surface markers (using directly labelled anti-CD45, anti-CD1c and anti-CD14 Abs), cells were washed, fixed and permeabilised with Cytofix/Cytoperm buffer (BD Biosciences) and stained with FITC-labelled anti-IL-6 (BioLegend). Acquisition was performed on a FACSVerse flow cytometer (BD Biosciences) and FlowJo analysis software (Treestar) was used for data analysis. Flow Cytometry Cell Sorting (FACS) was performed using the ARIA SORP (Becton Dickinson, Franklin Lakes, NJ). Anti-CD45, anti-CD1c and anti-CD14 sterile antibodies were used.
Briefly, 2 days post injection tumour-free OSCs and OMCs were digested, under sterile conditions, and the cell suspensions filtered, stained and cells were sorted with >98% purity.
Mixed lymphocyte reaction and activated T cell phenotype
The ability of cDC2s (CD1c Table 1 ) and acquired at the FACSVerse (BD Biosciences).
Gene expression analysis
Total RNA was extracted from FACS-sorted immune cells using Trizol (Invitrogen), and cDNA was generated using the SuperScript II Reverse Transcriptase Kit (ThermoFisher Scientific). cDNA was then used as a template for messenger RNA (mRNA) amplification using the TranscriptAid T7 High
Yield Transcription Kit (Thermo Scientific). Amplified (aRNA) was purified using Agencourt RNAClean XP beads (Beckman Coulter, Brea, CA) prior to Nanodrop quantification. 500ng/mL of aRNA were used for reverse transcription with Superscript II (ThermoFisher Scientific). The resulting cDNA was used as a template. qPCR using FastStart SYBR Green Master (Roche Diagnostic GmbH) was performed on a CFX96 real-time cycler (Bio-Rad). The 2−ΔΔCt method, in which Ct represents the threshold cycle, was applied. Samples were run in triplicate. Relative gene expression was determined by normalizing the gene expression of each target gene to β-actin (ACTB). Primer sequences are listed in Supplementary Table 3 .
Statistical analysis
Statistical analysis was performed using GraphPad Prism V6. Values in the present study are Representative multicolor composite pictures for each panel are shown. Scale bar 50µm.
